Castleview Partners’s ArcBest ARCB Stock Holding History

Castleview Partners’s Portfolio ARCB Stock Details ARCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,382	Closed	-$120	–	724
2021 Q4	$120	Buy	+14,382	New	+$1.46M	﹤0.01%	762

Other funds holding ARCB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Castleview Partners's ARCB Position: Q1 2022 in Review

Castleview Partners sold out of ArcBest (ARCB) in Q1 2022, closing a stake of 14,382 shares — an estimated $120 sold.

Castleview Partners first reported a position in ARCB in Q4 2021 and held it in 1 quarter. The position peaked at $120 in Q4 2021. 263 funds tracked by Wall St. Rank hold ARCB as of Q1 2022.

Castleview Partners reported no remaining ArcBest position as of Q1 2022 after selling out during the quarter.
Castleview Partners sold 14,382 ArcBest shares in Q1 2022, an estimated $120.
Castleview Partners first reported a position in ArcBest in Q4 2021 and held it in 1 quarter.
Castleview Partners's ArcBest position peaked at $120 in Q4 2021.
263 funds tracked by Wall St. Rank held ArcBest as of Q1 2022.

Based on Castleview Partners's 13F filing for Q1 2022, filed 16 May 2022.